• research
• publications

Publications

• Morgan MA, Sill MW, Fujiwara K, Greer B, Rubin SC, DeGeest K, Yamada SD, Waggoner S, Coleman RL, Walker JL, Mannel RS. A phase I study with an expanded cohort to asses the feasibility of intraperitoneal carboplatin and intravenous paclitaxel in untreated ovarian, fallopian tube, and primary peritoneal carcinoma: A Gynecologic Oncology Group Study. Submitted 2010.
• Morgan MA, Polan ML, Melecot HH, Debru B, Sleemi A, Husain A. Experience with a low-pressure colonic pouch (Mainz II) urinary diversion for irreparable vesicovaginal fistula and bladder extrophy in East Africa. Int Urogynecol J, 2009 October; 20:1163-1168. PubMed
• Greer BE, Koh WJ, Abu-Rustum N, Bookman, MA, Bristow RE, Campos SM, Cho,KR, Copeland L, Crispens MA, Eifel PJ, Huh WK, Jagernauth W, Kapp DS, Kavanagh JJ, Lurain JR 3rd, Morgan MA, Morgan RJ, Powell CB, Remmenga SW, Reynolds RK, Alvarez Secord A, Small W Jr., Teng N. NCCN Clinical Practice Guidelines in Oncology: Uterine Neoplasms. J Natl Compr Canc Netw, 2009 May;7(5):498-531.
• Novi JM, Mulvihill BHK, Morgan, MA. Combined Anal Sphincteroplasty and Perineal Reconstruction for Fecal Incontinence in Women. JAOA, 2009 April;109, 4:234-236
• Morgan MA, Darcy KM, Rose PG, DeGeest K, Bookman MA, Aikins JK, Sill MW, Mannel RS, Allievi C, Egorin MJ. Paclitaxel poliglumex and carboplatin as first-line therapy in ovarian, peritoneal or fallopian tube cancer: A phase I and feasibility trial of the Gynecologic Oncology Group. Gynecologic Oncology 2008;110:329-335. PubMed
• Morgan, M. Intraperitoneal chemotherapy for ovarian cancer. Adv Exp Med Biol. 2008;622:145-51. PubMed
• Morgan, M. The main site of origin for malignancies detected during risk- reducing surgery for ovarian cancer. Nat Clin Pract Oncol. 2008 March; 5(3):134-5. PubMed
• Partridge EE, Abu-Rustum N, Campos S, Fahey PJ, Greer BE, Lele SM, Lieberman RW, Lipscomb GH, Morgan M, Nava ME, Reynolds RK, Singh DK, Smith-McCune K, Teng N, Trimble CL, Valea F, Wilczynski S. Cervical cancer screening. J Natl Compr Canc Netw. 2008 Jan;6(1):58-82. PubMed
• Greer BE, Koh WJ, Abu-Rustum N, Bookman MA, Bristow RE, Campos S, Cho KR, Copeland L, Eifel P, Huh WK, Jaggernauth W, Kapp DS, Kavanagh J, Lipscomb GH, Lurain JR 3rd, Morgan M, Morgan RJ Jr, Powell CB, Remmenga SW, Reynolds RK, Secord AA, Small W Jr, Teng N; National Comprehensive Cancer Network. Cervical cancer. J Natl Compr Canc Netw. 2008 Jan;6(1):14-36. PubMed
• Kavanagh JJ, Sill MW, Ramirez PT, Warshal D, Pearl ML, Morgan MA. Phase II multicenter open-label study of karenitecin in previously treated epithelial ovarian and primary peritoneal cancer: A Gynecologic Oncology Group Study. Int J Gynecol Cancer. 2008 May-Jun;18(3):460-4. PubMed
• Novi JM, Bradley CS, Mahmoud NN, Morgan MA, Arya LA. Sexual function in women after rectocele repair with acellular porcine dermis graft vs site-specific rectovaginal fascia repair. Int Urogynecol J Pelvic Floor Dysfunct. 2007 Oct;18(10):1163-9. PubMed
• Srinivasan R, Yang Y, Rubin, SC, Morgan, MA, Lewis, JD. Risk of colorectal cancer in women with a prior diagnosis of gynecologic malignancy. J Clin Gastroenterol. 2007 Mar;41(3):291-6. PubMed
• Fujiwara K, Armstrong D, Morgan M, Markman M. Principles and practice of intraperitoneal chemotherapy for ovarian cancer. Int J Gynecol Cancer. 2007 Jan-Feb;17(1):1-20. PubMed
• Brewer CA, Blessing JA, Nagourney RA, Morgan MA, Hanjani P. Cisplatin plus gemcitabine in platinum-refractory ovarian or primary peritoneal cancer: a phase II study of the Gynecologic Oncology Group. Gynecol Oncol. 2006 Nov;103(2):446-50. PubMed